了解肝细胞癌诊断和治疗的肠道失生症

Jingjing Yu1, Xiaoping Chen2, Xiangliang Yang3

  • 1Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China; Hubei Key Laboratory of Hepato-Pancreatic-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

概括

肠道微生物群影响肝癌 (肝细胞癌/HCC) 的进展和免疫反应. 调节肠道细菌为HCC提供了作为辅助治疗和诊断生物标志物的潜力.